HR 1409
115th Congress
House
Health
Cancer
Drug therapy
Health care costs and insurance
Health care coverage and access
Prescription drugs
Cancer Drug Parity Act of 2017
Introduced: March 7, 2017
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 17, 2017
Referred to the Subcommittee on Health.
Mar 7, 2017
Referred to the House Committee on Energy and Commerce.
Mar 7, 2017
Introduced in House
Plain-English summary
Cancer Drug Coverage Act of 2017
This bill amends the Public Health Service Act to require group and individual health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medication approved by the Food and Drug Administration that is prescribed based on a finding by the treating physician that the medication is medically necessary for cancer treatment and is clinically appropriate in terms of type, frequency, extent site, and duration.
To comply with this requirement, health plans may not, for anticancer medications: (1) change or replace benefits to increase out-of-pocket costs; (2) reclassify benefits to increase costs; or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2